Brain Pharm: Brain Pharmacology Database User: Public
SenseLab  Home Data Search Schema Login	[Data] Pathological mechanism Name beta-Amyloid-induced depression of LTP attenuated by Verapamil Description Hypothesis LTP hypothesis   show other Extracelular pathological element β-Amyloid   show other Intracelular pathological element Pathological action Reduces   show other Process LTP   show other Process action Activates   show other Transmitter(s) Receptor(s) Channel(s) I L high threshold   show other Pharmacological Agent Verapamil   show other Pharmacological Action Blocks   show other Brain region Hippocampus   show other Neuron Cell model Cellular compartment PubMed ID 12611943 Citation 12611943   show other AlzWeb Notes Experimental findings suggest that verapamil, an L-type (VDCC) calcium channel blocker may be useful in the cognitive deficits associated with AD (Freir DB et al. 2003) Pathology Alzheimer   show other Stage Early   show other Question Claim Other categories referring to "beta-Amyloid-induced depression of LTP attenuated by Verapamil"   Revisions: 8 Last time: 9/9/2008 10:50:52 AM Reviewer: Pradeep Mutalik Owner: EAV/CR Schema Administrator
	Questions, comments, problems? Email the Database Administrator This site is Copyright 2010, Yale Center for Medical Informatics